Immune checkpoints in thymic epithelial tumors: challenges and opportunities

Thymic malignancies are rare mediastinal cancers, classified according to the World Health Organization's histopathologic classification which distinguishes thymomas from thymic carcinomas. One key consideration when discussing immunotherapy for thymic epithelial tumors is that one-third of pat...

Descripción completa

Detalles Bibliográficos
Autor principal: Girard, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216246/
https://www.ncbi.nlm.nih.gov/pubmed/35757304
http://dx.doi.org/10.1016/j.iotech.2019.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216246/
https://www.ncbi.nlm.nih.gov/pubmed/35757304
http://dx.doi.org/10.1016/j.iotech.2019.09.002

Ejemplares similares